BR0210057A - Composição compreendendo agentes antifúngicos para tratar vulvovaginite e vaginose - Google Patents
Composição compreendendo agentes antifúngicos para tratar vulvovaginite e vaginoseInfo
- Publication number
- BR0210057A BR0210057A BR0210057-6A BR0210057A BR0210057A BR 0210057 A BR0210057 A BR 0210057A BR 0210057 A BR0210057 A BR 0210057A BR 0210057 A BR0210057 A BR 0210057A
- Authority
- BR
- Brazil
- Prior art keywords
- antifungal agents
- vaginosis
- compositions
- composition
- vagina
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Abstract
"COMPOSIçãO COMPREENDENDO AGENTES ANTIFúNGICOS PARA TRATAR VULVOVAGINITE E VAGINOSE". Esta invenção refere-se a composições e métodos para tratar vulvovaginite e vaginose. As composições desta invenção contêm agentes antifúngicos bem como um sistema de tamponamento que, quando administradas na vagina de uma paciente, mantém o pH da vagina de modo a obter um ambiente saudável que estimule o desenvolvimento de flora adequada. Agentes antifúngicos que são úteis nas composições desta invenção incluem agentes antifúngicos azólicos. Sistemas de tamponamento incluem gluconodeitalactona.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28794201P | 2001-05-01 | 2001-05-01 | |
US10/109,097 US20030064103A1 (en) | 2001-05-01 | 2002-03-28 | Compositions and methods for treating vulvovaginitis and vaginosis |
US10/128,611 US20030017207A1 (en) | 2001-05-01 | 2002-04-23 | Compositions and methods for treating vulvovaginitis and vaginosis |
PCT/US2002/012749 WO2002087570A1 (en) | 2001-05-01 | 2002-04-24 | Composition comprising antifungal agents for treating vulvovaginitis and vaginosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0210057A true BR0210057A (pt) | 2004-08-17 |
Family
ID=27380599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0210057-6A BR0210057A (pt) | 2001-05-01 | 2002-04-24 | Composição compreendendo agentes antifúngicos para tratar vulvovaginite e vaginose |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030017207A1 (pt) |
EP (1) | EP1385511A1 (pt) |
JP (1) | JP2004529935A (pt) |
CN (1) | CN1522145A (pt) |
BR (1) | BR0210057A (pt) |
CA (1) | CA2446052A1 (pt) |
MX (1) | MXPA03010022A (pt) |
WO (1) | WO2002087570A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060105008A1 (en) | 2002-03-28 | 2006-05-18 | Nawaz Ahmad | Compositions and methods for reducing vaginal pH |
US7695730B2 (en) | 2002-05-01 | 2010-04-13 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
US7417013B2 (en) | 2002-05-01 | 2008-08-26 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
US7005408B2 (en) | 2002-05-01 | 2006-02-28 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
ATE396705T1 (de) * | 2002-05-01 | 2008-06-15 | Mcneil Ppc Inc | Erwärmende und nicht irritierende antifungale schmiermittelzubereitung in gelform |
US7658941B2 (en) | 2002-05-01 | 2010-02-09 | Johnson & Johnson Consumer Companies, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
US9241997B2 (en) * | 2003-06-13 | 2016-01-26 | Idh Holding Aps | Treatment of symptoms associated with bacterial vaginosis |
US8309103B2 (en) * | 2004-01-22 | 2012-11-13 | Alparis, S.A. De C.V. | Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
AU2006209263A1 (en) * | 2005-09-12 | 2007-03-29 | Mcneil-Ppc, Inc. | Anhydrous composition containing an acid-acid buffer system |
US7851419B2 (en) | 2005-09-12 | 2010-12-14 | Nawaz Ahmad | Substantially anhydrous sprayable personal lubricant |
NL1030438C2 (nl) * | 2005-11-16 | 2007-05-21 | Happy Foot | Samenstelling met schimmelwerende eigenschappen, gebruik en werkwijze. |
WO2007102241A1 (ja) * | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
RU2415669C2 (ru) | 2006-03-08 | 2011-04-10 | Нихон Нохияку Ко., Лтд. | Фармацевтическая композиция для наружного применения |
CA2645070C (en) * | 2006-03-08 | 2014-02-04 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
ES2591030T3 (es) * | 2007-09-05 | 2016-11-24 | Pola Pharma Inc. | Composición farmacéutica antifúngica |
JP5345937B2 (ja) * | 2007-09-05 | 2013-11-20 | 株式会社ポーラファルマ | 抗真菌組成物 |
WO2009031642A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
RU2504379C2 (ru) * | 2008-04-24 | 2014-01-20 | Индена С.П.А. | Композиции для лечения вагинальных инфекций с хроническим воспалением |
US20100105750A1 (en) * | 2008-10-23 | 2010-04-29 | Nycomed Us Inc. | Stable metronidazole gel formulations |
EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
KR101754697B1 (ko) | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
AU2010305200B2 (en) | 2009-10-08 | 2014-10-02 | Phlora Bio-Technology Investment Limited | Composition comprising benzoic acid in combination with organic acid preservatives as active components and use thereof |
CN102293735B (zh) * | 2011-08-19 | 2013-05-01 | 辽宁万嘉医药科技有限公司 | 一种抗真菌咪唑类药物缓释凝胶和制备方法 |
JP6341200B2 (ja) * | 2013-05-30 | 2018-06-13 | 大正製薬株式会社 | 坐剤 |
CN104815096B (zh) * | 2015-05-04 | 2019-10-11 | 中国人民解放军疾病预防控制所 | 一种纳米复合皮肤消毒乳液及其制备方法 |
RU2017146425A (ru) * | 2015-05-29 | 2019-07-02 | Ив Фарма Лтд. | Pн-зависимые вагинальные композиции и способы лечения вагинальных нарушений |
PL3439633T3 (pl) * | 2016-04-06 | 2022-01-10 | Gedea Biotech Ab | Glukono-delta-lakton w leczeniu zakażeń grzybiczych pochwy |
CA3134086A1 (en) * | 2019-04-05 | 2020-10-08 | Gedea Biotech Ab | Vaginal tablet formulation |
CN112933109A (zh) * | 2021-02-03 | 2021-06-11 | 湖南奥朗特医疗器械有限公司 | 一种阴道pH调节剂及其制备方法和应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0024023B2 (de) * | 1979-08-11 | 1992-11-11 | Bayer Ag | Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe |
JPS58164683A (ja) * | 1982-03-25 | 1983-09-29 | Takeda Chem Ind Ltd | 安定化された固体組成物 |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
US6017521A (en) * | 1989-10-31 | 2000-01-25 | Columbia Laboratories, Inc. | Use of polycarboxylic acid polymers to treat vaginal infections |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5514698A (en) * | 1994-03-21 | 1996-05-07 | Ortho Pharmaceutical Corporation | Antifungal vaginal cream composition |
US5592949A (en) * | 1994-06-29 | 1997-01-14 | Moench; Thomas R. | Device for acidic buffering and method for inactivation of pathogens |
US5939485A (en) * | 1995-06-19 | 1999-08-17 | Medlogic Global Corporation | Responsive polymer networks and methods of their use |
US6069126A (en) * | 1996-09-12 | 2000-05-30 | Merck & Co., Inc. | Antifungal combination therapy |
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
WO1998058654A1 (fr) * | 1997-06-20 | 1998-12-30 | Ohkura Pharmaceutical Co., Ltd. | Composition sous forme de gel |
WO1999003459A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
ATE304362T1 (de) * | 1997-11-24 | 2005-09-15 | Zhongming Zeng | Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung |
FR2777783A1 (fr) * | 1998-04-24 | 1999-10-29 | Innothera Lab Sa | Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses |
-
2002
- 2002-04-23 US US10/128,611 patent/US20030017207A1/en not_active Abandoned
- 2002-04-24 BR BR0210057-6A patent/BR0210057A/pt not_active IP Right Cessation
- 2002-04-24 WO PCT/US2002/012749 patent/WO2002087570A1/en not_active Application Discontinuation
- 2002-04-24 MX MXPA03010022A patent/MXPA03010022A/es unknown
- 2002-04-24 EP EP02736600A patent/EP1385511A1/en not_active Withdrawn
- 2002-04-24 CA CA002446052A patent/CA2446052A1/en not_active Abandoned
- 2002-04-24 JP JP2002584916A patent/JP2004529935A/ja active Pending
- 2002-04-24 CN CNA028130863A patent/CN1522145A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004529935A (ja) | 2004-09-30 |
US20030017207A1 (en) | 2003-01-23 |
EP1385511A1 (en) | 2004-02-04 |
WO2002087570A1 (en) | 2002-11-07 |
CN1522145A (zh) | 2004-08-18 |
CA2446052A1 (en) | 2002-11-07 |
MXPA03010022A (es) | 2005-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210057A (pt) | Composição compreendendo agentes antifúngicos para tratar vulvovaginite e vaginose | |
BR0308854A (pt) | Benzazolas substituìdas e seus usos como inibidoras de quinase raf | |
BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
BRPI0413255A (pt) | uso de uma combinação de um inibidor de quinase do receptor do fator de crescimento epidérmico e agentes citotóxicos para tratamento e inibição do cáncer | |
BRPI0507895A (pt) | composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
BR0310099A (pt) | método para tratar dislipidemia ou uma doença associada com a dislipidemia | |
BRPI0408784A (pt) | método para usar um composto | |
BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
BR0311939A (pt) | composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico | |
BRPI0517481A (pt) | método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica | |
BR9916076A (pt) | Composição adequada para aplicação tópica, uso de uma composição tópica métodos para melhorar o distúrbio do estìmulo sexual feminino, e para intensificar o estìmulo sexual feminino, e a resposta sexual feminina, artigo de manufatura | |
BR0316305A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, métodos para tratar a dor em um animal, para estimular a função do receptor opióide em uma célula, para preparar uma composição, e para tratar diarréia em um animal, composição, e kit | |
BRPI0410306A (pt) | métodos para tratar, controlar ou evitar um cáncer especìfico, para tratar, controlar ou evitar uma doença associada com angiogênese indesejada e para reduzir ou evitar um efeito adverso, composição farmacêutica, e, kit | |
EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
BRPI0518999A2 (pt) | composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha | |
BR0013010B1 (pt) | Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina | |
DE60040753D1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
BRPI0612840A8 (pt) | Composição de ração para prevenir ou tratar doença renal, métodos para prevenir ou tratar doença renal e para produzir uma composição de ração, kit, e, meio para comunicar informação ou instruções | |
DK1401422T3 (da) | Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
EE200200565A (et) | Vaskulaarse kahjustava toimega kombinatsioonravi | |
DK1392328T3 (da) | Medikament til beskyttelse i radioterapi | |
BR0011225A (pt) | Agente para tratar de olhos secos, seu método e uso | |
BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: JOHNSON & JOHNSON (US) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A., 7A., E 8A., ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |